NCT00019474View on ClinicalTrials.gov

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions

Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid TumorLiver CancerPancreatic CancerSmall Intestine Cancer

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon alfa

DRUG

fluorouracil

DRUG

hydroxyurea

Trial Locations (1)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Montefiore Medical Center

OTHER

NCT00019474 - Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | Biotech Hunter | Biotech Hunter